Tassos Konstantinou

Tassos is an investment manager at IP Group and specializes in early stage investing in the life science sector. Before joining IP Group, Tassos was a business development executive at CRUK Commercial Partnerships (formerly CRT) where he led the intellectual property sourcing, licensing, and spin-out creation of CRUK-funded technologies. He has experience in technology transfer both in the US and the UK, and has also held an investment analyst role with SR One, GSK’s venture capital arm. Tassos earned a PhD in Molecular Oncology at the University of Oxford and a postdoc at the University of Chicago.